The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health

Christina S. Thornton(University of Calgary), Dina A. Fisher(University of Calgary), Stephen K. Field(University of Calgary), Madeline Mellett(University of Calgary), Julie Jarand(University of Calgary), Leila Barss(University of Calgary)
European Respiratory Review
May 25, 2021
10.1183/16000617.0299-2020
Cited by 45

Related Papers

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
|PubMed|2007|653
Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma
|JAMA|2017|442
Overdiagnosis of asthma in obese and nonobese adults
|Canadian Medical Association Journal|2008|409
Treatment of Unexplained Chronic Cough
|CHEST Journal|2015|360
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized Study
|American Journal of Respiratory and Critical Care Medicine|2018|343